| INTRODUC TI ON
Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. Nearly half of the disease burden occurs in Eastern Asia, particularly in China, South Korea, and Japan. 1 GC can be subdivided into intestinal type and diffuse type based on Lauren's classification. 2 The development of noncardia intestinal-type GC follows a well-defined histological sequence of progression in Helicobacter pylori (H. pylori, Hp)-infected gastric mucosa, initiating as chronic gastritis followed by atrophy, intestinal metaplasia, dysplasia, and GC. [3] [4] [5] [6] H. pylori infection is the known single most important factor for GC, and eradication of H. pylori not only cures gastritis but also prevents the progression to long-term complications, such as atrophic gastritis, intestinal metaplasia, recurrence of ulcers and reduces the incidence of GC.
However, how H. pylori infection results in the initiation of GC remains unknown.
Histone modification plays important roles in various cellular functions and cancer; they affect gene expression by changing the state of transcription factors accessing to chromatin. [7] [8] [9] [10] [11] The post-translational modification of histone tails also affects different levels of DNA organization, including acetylation, phosphorylation, methylation, ubiquitylation, and ADP ribosylation on it amino acid residues, 8, [11] [12] [13] the combination of these modifications are important marks of epigenetics, commonly known as "histone code."
Increasing evidences have indicated its role in tumor initiation and development.
14 Several reports have indicated that histone H3 serine 10 (H3Ser10) is involved in epithelial carcinogenesis. For example, phosphorylation of H3Ser10 (p-H3Ser10) is an essential regulatory mechanism for epidermal growth factor (EGF)-induced neoplastic cell transformation, which involves the induction of c-fos and c-jun promoter activity. 15, 16 Overexpression of phosphorylated histone H3 in gastric tissue has been reported as an indicator of poor prognosis in gastric adenocarcinoma patients. 17 Increased p-H3Ser10 is critical in EB virus-induced carcinogenesis of nasopharyngeal carcinoma; 18 active protein-1, mitogen-and stress-activated kinase 1 (MSK1) kinase activity and phosphorylation also participate in this process. 18 Our previous work has demonstrated that H. pylori infection alters histone modification and host response via cagPAIdependent mechanisms; we showed that wild-type H. pylori induced time-and dose-dependent dephosphorylation of H3Ser10 and decreased acetylation of H3 lysine 23 (H3K23ac), but have no effects on seven other specific modifications. 19 However, whether H. pylori infection affects histone modifications in human stomach and its role in gastric carcinogenesis remains elusive.
In this report, we evaluate the expression pattern of p-H3Ser10 in stomach biopsy samples in chronic gastric disease and patients with GC, and assess its role in the stepwise gastric disease progress.
The results indicate a strong correlation of histone H3Ser10 phosphorylation with chronic gastric disease progression and implicate its role in H. pylori-induced gastric carcinogenesis. antibodies, respectively. Olympus microscopes (BX43, Olympus, Tokyo, Japan) were used to observe the section and take photographs for staining evaluation.
| MATERIAL S AND ME THODS

| Patients
| Evaluation of immunostaining
Immunostaining results were scored as described previously. [20] [21] [22] All sections were evaluated blindly by two independent reviewers (Song 
| Statistical analysis
The data were analyzed using SPSS for Windows (Version 22, IBM Corp., New York, NY, USA). All data were tested for normal distribution by Kolmogorov-Smirnov test and for homogeneity of variances by Levene's test. Data of normal distribution and similar variances were tested by Student's "t" test for two independent samples comparison, and ANOVA was used for multiple comparisons among different groups and all data expressed as mean ± standard deviation (SD). Comparison of ratios between different groups was made by chi-square test. The correlations of LI among different groups were assessed using Spearman's correlation coefficient test. P < .05 was considered statistically significant, which was derived from two-tailed tests. The variance was of highly statistically significant when P < .01.
| RE SULTS
| Correlation of patient clinical data with H. pylori infection status
A total of 129 patients were analyzed in this study; their average age is 59 (range from 13 to 82) years. The clinicopathological characteristics are summarized in 
| Labeling index of p-H3Ser10 and Ki-67 in H. pylori-infected and noninfected groups
A total of 59 patients were grouped into H. pylori-positive and 70 patients in H. pylori-negative groups; total LI of p-H3Ser10 and Ki-67 was compared between the two groups. We noted that H. pylori infection increased overall LI of p-H3Ser10 significantly when compared with H. pylori-negative group (6.31 ± 2.22 vs 5.35 ± 2.10, P < .05); there was no difference on the overall level of Ki-67 expression between two groups (P > .05) ( Table 2) . However, H. pylori induced higher Ki-67 expression level in intestinal-type GC over noninfected GC controls (P < .01, Table 3 ). Representative IHS images of p-H3Ser10 in different groups are presented in Figure 1 . Both Ki67 and H3Ser10 phosphorylation showed mild to strong nuclear expression.
| Labeling index of p-H3Ser10 and Ki-67 among different stages of gastric disease
In H. pylori-negative patient groups, LI of p-H3Ser10 was increased as disease progress from NAG to CAG, IM, and LGIN groups, and peaked at LGIN; its level declined in HGIN and GC groups ( Figure 2A) . In H. pylori-infected groups, LI of p-H3Ser10 followed the similar pattern as above; however, increased LI of pH3Ser10 was noted in all groups when compared with H. pylorinegative groups, except in NAG group, whose expression level was lower when compared with H. pylori-negative NAG group (P < .05, Figure 2B and Table 3 ).
The general LI of Ki67 showed a trend of gradually increasing from NAG stage to GC stage groups, except slightly decreased in CAG groups. In H. pylori-negative groups, the LI of Ki67 was significantly higher in GC than that in CAG and LGIN groups (P < .05); and in IM group compared with CAG group (7.79 ± 1.06 vs 5.82 ± 1.50, P < .01) ( Figure 2C and Table 3 ). In H. pylori-infected patients, Ki67
LI followed the similar pattern as in H. pylori-negative groups and peaked at GC groups (P < .01); higher level of Ki67 LI in HGIN was noticed when compared with CAG group (P < .05) ( Figure 2D and Table 3 ).
Irrespective of H. pylori infection status, the overall staining level of p-H3Ser10 and Ki-67 in H. pylori-positive and -negative polled groups showed similar pattern as H. pylori-infected patient group as disease progress from NAG to GC stages of disease ( Figure 2E and 2F).
To explore the correlation between p-H3Ser10 and Ki-67 among all these disease groups, Spearman's correlation coefficient was used to assess their relationship; the results indicated that there was no significant correlation between p-H3Ser10 and Ki-67 LI among different disease groups (P > .05).
| Location changes in p-H3Ser10-and Ki-67-stained cells among various stages of gastric disease
As location of p-H3Ser10-and Ki-67-stained cell in gastric gland may be closely linked to its function, and their distribution in stepwise gastric carcinogenesis has not been explored, we therefore investigated their location changes during disease progress. The results indicated that locations of p-H3Ser10-stained cells were gradually moved from bottom of gastric gland to the whole gland distribution as disease progress from benign stage to GC.
In H. pylori-negative groups, approximately half of the p-H3Ser10-stained cells located at bottom of gastric gland in NAG, CAG, and IM groups, and they start to spread to the body, neck, and whole gland as disease progress from LGIN to GC stage of disease (67.86% to 98.08%) ( Figure 3A) . In H. pylori-positive groups, similar distribution pattern of p-H3Ser10-stained cells was noticed as in H. pylori-negative groups, but staining level of p-H3Ser10-positive cells located in the bottom of gastric gland was higher in NAG group than that in H. pylori-negative NAG controls (76.5% vs 51.33%, Figure 3B ).
For Ki67, the positive stained cells mainly lie in the bottom of benign gastric gland in NAG, CAG, and IM groups; as disease progress, they start to become whole gland distribution ( Figure 3C and D).
There were no differences in the percentages of Ki67-stained cells in each location between H. pylori-infected and noninfected groups ( Figure 3C and D). MSK1-regulated increase of p-H3Ser10 in GC is predictive of a more aggressive phenotype; this also could help defining the true negative margin of surgical resection. 24 However, relatively few studies have investigated the role of H. pylori infection in these processes. 28 However, its regulation by H. pylori infection in human stomach has not been evaluated.
| D ISCUSS I ON
Our previous in vitro work has demonstrated that wild-type
H. pylori induced time-and dose-dependent dephosphorylation of
H3Ser10 and decreased H3K23ac in gastric epithelial cells, which is cagPAI-dependent. 19 Several commonly expressed genes, including CXCL8, PTGS2, CXCL2, PRKDC, DUSP4, and CCND1, are not associated with or are independent of dephosphorylation of H3Ser10.
However, altered JUN and HSP70 gene expression is associated with H3Ser10 dephosphorylation. 19 The present work has enriched the previously founding and noted the impact of H. pylori infection on p-H3Ser10 expression at various stages of gastric carcinogenesis. Moreover, there appears to be no strict linkage to cancer progression. 
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